IRAN FIRST

Iran moves toward self-sufficiency in two vital vaccines, cutting $20m in import costs

Iranian knowledge-based companies are making progress toward domestic production of pneumococcal and meningococcal vaccines, two vital immunization products that cost the country nearly $20 million in foreign currency imports last year.